Follicular lymphoma: past, present, and future

MR Becnel, LJ Nastoupil - Current treatment options in oncology, 2018 - Springer
… initiation and in selection of first-line agents. Ardeshna et al. have … since its development in
the late 1990s. When compared to … first-line immunochemotherapy for follicular lymphoma: a …

Follicular lymphoma: 2020 update on diagnosis and management

A Freedman, E Jacobsen - American journal of hematology, 2020 - Wiley Online Library
Disease overview Follicular lymphoma (FL) is generally an indolent B cell lymphoproliferative
disorder of transformed follicular center B cells. Follicular lymphoma is characterized by …

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

CL Batlevi, F Sha, A Alperovich, A Ni, K Smith… - Blood cancer …, 2020 - nature.com
… was associated with inferior survival following first-line treatment. The reduced survival we
observed after second-line and later therapy supports the development of new treatments for …

How we manage follicular lymphoma

W Hiddemann, BD Cheson - Leukemia, 2014 - nature.com
… Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis
of … CVP as first-line treatment for advanced follicular lymphoma. Blood 2005; 105: 1417–1423. …

Effectiveness of first-line management strategies for stage I follicular lymphoma: analysis of the National LymphoCare Study

JW Friedberg, M Byrtek, BK Link, C Flowers… - Journal of clinical …, 2012 - ascopubs.org
… with newly diagnosed follicular lymphoma from 2004 to 2007 … with de novo stage I follicular
lymphoma. Less than one third … of patients with stage I follicular lymphoma treated with these …

Follicular lymphoma

A Carbone, S Roulland, A Gloghini, A Younes… - Nature reviews Disease …, 2019 - nature.com
… Thus, the GC B cells must accumulate further oncogenic hits during the later phases of B …
However, several lines of evidence have also demonstrated a pivotal role for some of those (…

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a …

C Casulo, MC Larson, JJ Lunde… - The Lancet …, 2022 - thelancet.com
… To inform clinical research efforts with an expert practice-based scenario including patient
characteristics and outcomes in the third-line setting or later, we developed the Lymphoma

Follicular lymphoma: evolving therapeutic strategies

BS Kahl, DT Yang - Blood, The Journal of the American Society …, 2016 - ashpublications.org
… Recent discoveries have identified patients at high risk for poor outcomes to first-line therapy
(m7–Follicular Lymphoma International Prognostic Index [m7-FLIPI]) and for poor outcomes …

How do I sequence therapy for follicular lymphoma?

G Salles - Hematology 2014, the American Society of …, 2020 - ashpublications.org
… with follicular lymphoma. (A) Treatment options for patients who did not receive
immunochemotherapy in the first line. (B) … , which can be useful in later lines, specifically if …

Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020 …

G Kanas, W Ge, RGW Quek, K Keeven… - … & lymphoma, 2022 - Taylor & Francis
… of follicular lymphoma patients to DLBCL in later lines … -line or later therapy secondary to
advancing age, cumulative treatment-associated toxicity, the transformation of their lymphoma